Use of the gdf-5 mutant for the treatment of pain and cartilage destruction

The present invention is directed to the use of the GDF-5 mutant with an amino acid exchange R399E for the treatment of cartilage defects and pain and a pharmacological composition of said GDF-5 mutant.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GIGOUT Anne, KLEINSCHMIDT-DOERR Kerstin, WERKMANN DANIELA
Format: Patent
Sprache:eng ; heb
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The present invention is directed to the use of the GDF-5 mutant with an amino acid exchange R399E for the treatment of cartilage defects and pain and a pharmacological composition of said GDF-5 mutant.